Side Effects With a Focus on Lymphadenopathy Following COVID-19 Vaccination in Pediatric and AYA Oncology Patients

Belsky, J.; Carroll, Whitney R.; Xu, Guang; Jacob, S.

doi:10.1097/MPH.0000000000002621

MLA citation style (9th ed.)

Belsky, J, et al. Side Effects With a Focus On Lymphadenopathy Following Covid-19 Vaccination In Pediatric and Aya Oncology Patients. Wolters Kluwer Health, Inc. . 2023. marian.palni-palci-staging.notch8.cloud/concern/generic_works/e71b2069-8a55-4e5f-965b-13620cd982bc?locale=it.

APA citation style (7th ed.)

B. J, C. W. R, X. Guang, & J. S. (2023). Side Effects With a Focus on Lymphadenopathy Following COVID-19 Vaccination in Pediatric and AYA Oncology Patients. https://marian.palni-palci-staging.notch8.cloud/concern/generic_works/e71b2069-8a55-4e5f-965b-13620cd982bc?locale=it

Chicago citation style (CMOS 17, author-date)

Belsky, J., Carroll, Whitney R., Xu, Guang, and Jacob, S.. Side Effects With a Focus On Lymphadenopathy Following Covid-19 Vaccination In Pediatric and Aya Oncology Patients. Wolters Kluwer Health, Inc.. 2023. https://marian.palni-palci-staging.notch8.cloud/concern/generic_works/e71b2069-8a55-4e5f-965b-13620cd982bc?locale=it.

Note: These citations are programmatically generated and may be incomplete.

The Coronavirus Disease 2019 (COVID-19) pandemic led to the swift development of multiple vaccinations. Vaccine side effects were well-documented in the healthy adult cohort and included fever and lymphadenopathy, however, side effects in the pediatric immunocompromised population have not been reported. This retrospective study investigated vaccine-eligible children and adolescent young adult oncology patients 12 to 35 years old. We found uncommon, mild, and self-limiting side effects among pediatric cancer patients and survivors. This data will help guide pediatric and AYA oncologists in providing anticipatory guidance and serve as a guide to managing lymphadenopathy as a potential confounder of malignancy.

Creator

Publisher